Publication | Closed Access

Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension

HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseasePhysiologyOral Endothelin-receptorantagonist BosentanPulmonary HypertensionVascular BiologyEchocardiographicand Doppler MeasuresCardiovascular FunctionPublic HealthMedicineCardiologyPulmonary Vascular DiseaseAnesthesiologyCardiovascular Imaging